ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Outcomes of Patients With Hepatocellular Carcinoma Receiving a Donation After Cardiac Death Liver Graft

W. Goldkamp,1 J. Vanatta,2,3 S. Nair,2,3 E. Wong,3 N. Dbouk.2,3

1Internal Medicine, The Universty of Tennessee Health Science Center, Memphis, TN
2Surgery, The Universty of Tennessee Health Science Center, Memphis, TN
3Methodist Universty Hospital Transplant Institute, Memphis, TN.

Meeting: 2015 American Transplant Congress

Abstract number: D175

Keywords: Donors, Graft survival, Liver transplantation, non-heart-beating

Session Information

Session Name: Poster Session D: Liver Transplantation for Hepatocellular Carcinoma

Session Type: Poster Session

Date: Tuesday, May 5, 2015

Session Time: 5:30pm-6:30pm

 Presentation Time: 5:30pm-6:30pm

Location: Exhibit Hall E

Background: Recent data suggests that patients with Hepatocellular carcinoma (HCC) who receive a donation after cardiac death (DCD) graft have inferior graft and patient survival compared to patients with HCC receiving a donation after brain death (DBD) graft. We aimed to determine the causes for this discrepancy in outcomes.

Methods: Outcomes of 11 patients with HCC who received a DCD liver graft at our institution between 2006 and 2013 (HCC-DCD) were compared to those of a control group of 33 patients with HCC who received a DBD graft (HCC-DBD). Both groups were matched for age, gender, BMI and etiology of liver disease. Patient and graft survival rates for HCC-DCD patients were also compared to those of 50 patients without HCC who received a DCD organ (non HCC-DCD group) during the same time period.

Results: Baseline characteristics including tumor stage were similar between patients in the HCC-DCD and HCC-DBD groups. There was no significant difference in perioperative transfusion requirements or length of ICU stay and mechanical ventilation. There was also no significant difference in the incidence of rejection, hepatic artery thrombosis, infections requiring hospitalization and cardiovascular events between both groups. Graft survival rates were also similar between both groups. Biliary complications (bile leaks, anastomotic and non-anastomotic strictures)occurred in 45% of HCC-DCD patients vs.12% of HCC-DBD patients (p=0.02; OR=6 [1.24-29]). HCC recurred in 0 patients in the HCC-DCD group and 3(9%) in the HCC-DBD group (p=0.4). Patient survival was similar between both groups [figure 1]. There was also no significant difference in patient or graft survival between patients in the HCC-DCD and non HCC-DCD groups.

Conclusion:Patients with HCC who received a DCD liver had more biliary complications compared to patients with HCC receiving a DBD liver however this did not impact graft and patient survival. No difference in HCC recurrence rates was observed.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Goldkamp W, Vanatta J, Nair S, Wong E, Dbouk N. Outcomes of Patients With Hepatocellular Carcinoma Receiving a Donation After Cardiac Death Liver Graft [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/outcomes-of-patients-with-hepatocellular-carcinoma-receiving-a-donation-after-cardiac-death-liver-graft/. Accessed May 9, 2025.

« Back to 2015 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences